Anna Richo, a graduate of Cornell University and the DePaul University College of Law, has nearly 30 years’ experience as an attorney. Anna Richo currently serves as an executive vice president and general counsel at UCB in Brussels, Belgium, focusing on intellectual property law and corporate compliance.
The DePaul University College of Law offers students a number of unique juris doctor programs. Restorative justice is just one of the many areas of law individuals can focus on. As alternative dispute-resolution practices gain popularity throughout the United States, many legal professionals are looking into the field of restorative justice. While students will learn about the practice in depth, the process could be summarized as creating a safe environment in which ideas can be exchanged, conflicts addressed, and forgiveness achieved.
Asylum and immigration law is another doctoral area of study at DePaul University College of Law. The school’s Asylum & Immigration Law Clinic provides hundreds of immigrants with legal support every year, which gives law students the perfect setting in which to learn. Students can also choose to focus on business law and taxation, child and family law, intellectual property law, and much more.
A former executive of Amgen, Inc., in 2012, Anna Richo joined UCB, a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions related to severe diseases of the immune system or of the central nervous system. A member of the UCB executive committee, Anna Richo performs duties as executive vice president and general counsel for the company and oversees all aspects of legal and corporate compliance.
In April 2014, UCB released the results of its Policy for Optimal Epilepsy Management (POEM) study. The study included 249 United States veterans who used the health data sharing network PatientsLikeMe for the first time. During the study, the participants connected with other patients on the site and had access to condition-specific tracking tools and educational resources. At the end of the six-week period, the participants completed an epilepsy self-management scale (ESMS) and an epilepsy self-efficacy scale (ESES), which was compared to their evaluations taken prior to the start of the study. Of the individuals, approximately 37 percent completed the assessments and showed an improvement in managing their epilepsy. ESMS increased from 140 to 143 and ESES jumped 10 points.
The results of this study indicate that when epilepsy patients interact with one another, their conditions improve. Further, the study was conducted in a relatively short time frame, showing that patients do not have to spend years adapting to online technology to benefit from it.